We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
+1.83%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$329M
AUM Growth
-$177M
Cap. Flow
-$118M
Cap. Flow %
-35.7%
Top 10 Hldgs %
93.53%
Holding
42
New
10
Increased
5
Reduced
10
Closed
15

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$12.8M
2
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$11.1M
3
WGS icon
GeneDx Holdings
WGS
+$5.43M
4
TQQQ icon
ProShares UltraPro QQQ
TQQQ
+$5.32M
5
IMMP
Immutep
IMMP
+$1.44M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$105M
2
QDEL icon
QuidelOrtho
QDEL
+$21.3M
3
ARKK icon
ARK Innovation ETF
ARKK
+$16.6M
4
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$11.5M
5
AGEN
Agenus
AGEN
+$7.49M

Sector Composition

Rank Sector Weight
1 Healthcare 97.79%
2 Energy 0.18%
3 Industrials 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$181M 54.93%
1,240,932
-820,470
-40% -$105M
QDEL icon
2
QuidelOrtho
QDEL
$1.14B
$48.5M 14.74%
499,263
-209,368
-30% -$21.3M
OPK icon
3
Opko Health
OPK
$1.25B
$18.3M 5.57%
7,252,756
-1,733,000
-19% -$5.05M
MRNA icon
4
Moderna
MRNA
$22.1B
$12.8M 3.89%
+89,700
New +$12.8M
MRTX
5
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$11.7M 3.57%
+175,000
New +$11.1M
AGEN
6
Agenus
AGEN
$275M
$9.03M 2.74%
237,230
-206,347
-47% -$7.49M
WGS icon
7
GeneDx Holdings
WGS
$1.84B
$8.3M 2.52%
199,556
+80,016
+67% +$5.43M
BCRX icon
8
BioCryst Pharmaceuticals
BCRX
$2.48B
$6.39M 1.94%
603,994
-1,116,739
-65% -$11.5M
CFRX
9
DELISTED
ContraFect Corporation
CFRX
$6.05M 1.84%
24,615
+187
+0.8% +$52.8K
FORA
10
DELISTED
Forian
FORA
$5.85M 1.78%
1,333,477
+71,437
+6% +$275K
TQQQ icon
11
ProShares UltraPro QQQ
TQQQ
$30.5B
$3.6M 1.09%
+300,000
New +$5.32M
PACB icon
12
Pacific Biosciences
PACB
$432M
$3.55M 1.08%
803,845
-421,550
-34% -$2.56M
IMMP
13
Immutep
IMMP
$57M
$3.16M 0.96%
1,557,325
+581,169
+60% +$1.44M
AXDX
14
DELISTED
Accelerate Diagnostics
AXDX
$2.43M 0.74%
244,579
-28,607
-10% -$253K
PFE icon
15
CALL
Pfizer
PFE
$144B
$1.51M 0.46%
+500,000
New +$25.5M
DMTK
16
DELISTED
DermTech, Inc. Common Stock
DMTK
$1.37M 0.42%
246,569
-406,338
-62% -$3.33M
CDAK
17
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$1.34M 0.41%
463,998
-40,604
-8% -$143K
PNT
18
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$884K 0.27%
+129,810
New +$993K
MRTX
19
CALL
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$753K 0.23%
+60,600
New +$3.85M
BCRX icon
20
CALL
BioCryst Pharmaceuticals
BCRX
$2.48B
$656K 0.2%
+350,000
New +$3.61M
VTNR
21
DELISTED
Vertex Energy, Inc
VTNR
$598K 0.18%
56,800
+1,800
+3% +$21.3K
BIIB icon
22
Biogen
BIIB
$30.4B
$492K 0.15%
2,412
– –
AWH
23
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$428K 0.13%
48,540
-92,583
-66% -$940K
SLNO
24
DELISTED
Soleno Therapeutics
SLNO
$394K 0.12%
142,133
– –
VTNR
25
CALL
DELISTED
Vertex Energy, Inc
VTNR
$49K 0.01%
+150,300
New +$1.78M
1
2

Similar funds

BIO
Blue Investment Opportunities Miami Beach, Florida $168M AUM 21.32% 1-Year Est. Return
OBWA
Oak Barrel Wealth Advisory Reston, Virginia $167M AUM
EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
AIMU
Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
ACA
AG Campbell Advisory Baltimore, Maryland $158M AUM

Oracle Investment Management's Q2 2022 Portfolio in Review

As of Q2 2022, Oracle Investment Management held 42 positions worth $329M, down 35% from $506M the previous quarter. Its ten largest holdings account for 94% of the portfolio.

Oracle Investment Management withdrew a net $118M in Q2 2022, closing 15 positions and reducing 10 holdings. Its most notable exit was ARK Innovation ETF, an estimated $16.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 95% a quarter earlier, followed by Energy and Industrials.

Against the trend, Oracle Investment Management opened a new position in Moderna worth $12.8M.

  • Oracle Investment Management's largest Q2 2022 buy was Moderna: 89,700 shares worth $12.8M.
  • Oracle Investment Management added most to GeneDx Holdings in Q2 2022, an estimated $5.43M increase.
  • Oracle Investment Management's biggest Q2 2022 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $105M.
  • Oracle Investment Management fully exited ARK Innovation ETF in Q2 2022, selling an estimated $16.6M.
  • Oracle Investment Management's ten largest holdings make up 94% of its $329M portfolio in Q2 2022.
  • Oracle Investment Management opened 10 new positions and closed 15 in Q2 2022.
  • Oracle Investment Management's portfolio value fell 35% quarter-over-quarter to $329M.

Based on Oracle Investment Management's 13F filing for Q2 2022, filed 15 Aug 2022.